$1.61
0.8099.65%
Last update: Oct 27, 6:03 AM
GlucoTrack Inc (GCTK) Stock Price, Quote, News & History
GCTKNASDAQ
GlucoTrack targets a Q2 2026 FDA IDE filing for CGM, backed by clinical data, manufacturing strategy, and reimbursement pathway.
You can purchase shares of GlucoTrack (NASDAQ:GCTK) through any online brokerage.
Other companies in GlucoTrack’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
There is no analysis for GlucoTrack to provide a consensus price target.
The stock price for GlucoTrack (NASDAQ: GCTK) is $1.52 last updated October 27, 2026 at 6:03 AM EDT.
There are no upcoming dividends for GlucoTrack.
GlucoTrack does not have any upcoming earnings scheduled.
There is no upcoming split for GlucoTrack.
GlucoTrack is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous...
